Active Ingredient History

NOW
  • Now
Casopitant (INN, tentative trade names Rezonic (U.S.), Zunrisa (Europe)) is a neurokinin 1 receptor (NK1R) antagonist undergoing research for the treatment of chemotherapy-induced nausea and vomiting (CINV). It is currently under development by GlaxoSmithKline (GSK).   Wikipedia

  • SMILES: C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1c2ccc(F)cc2C)N3CCN(CC3)C(=O)C)c4cc(cc(c4)C(F)(F)F)C(F)(F)F
  • InChIKey: XGGTZCKQRWXCHW-WMTVXVAQSA-N
  • Mol. Mass: 616.62
  • ALogP: 6.65
  • ChEMBL Molecules:
More Chemistry
casopitant | casopitant mesilate | casopitant mesylate | gw679769 | gw-679769 | zunrisa

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue